Target Identification/Validation with ECS Drug
Time: 11:55 am
day: Day 2 Track B - Morning
Details:
- In the context of Medpharm’s current research into degenerative disease, discuss key ideas involved in the
phase 1 study design process - Consider key target identification principles
